The SAP and SLAM families in immune responses and X-linked lymphoproliferative disease (original) (raw)
Purtilo, D. T., Cassel, C. K., Yang, J. P. & Harper, R. X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet1, 935–940 (1975). CASPubMed Google Scholar
Seemayer, T. A. et al. X-linked lymphoproliferative disease: twenty-five years after the discovery. Pediatr. Res.38, 471–478 (1995). CASPubMed Google Scholar
Morra, M. et al. Characterization of SH2D1A missense mutations identified in X-linked lymphoproliferative disease patients. J. Biol. Chem.276, 36809–36816 (2001). CASPubMed Google Scholar
Sumegi, J. et al. A spectrum of mutations in SH2D1A that causes X-linked lymphoproliferative disease and other Epstein–Barr virus-associated illnesses. Leuk. Lymphoma43, 1189–1201 (2002). CASPubMed Google Scholar
Schuster, V. & Terhorst, C. in Primary Immunodeficiency Diseases, Molecular and genetic approaches (Eds Ochs, H. M., Smith, C. E. & Puck, J. M.) (in the press)
Markin, R. S. et al. Hepatitis in fatal infectious mononucleosis. Gastroenterology93, 1210–1217 (1987). CASPubMed Google Scholar
Mroczek, E. C., Weisenburger, D. D., Grierson, H. L., Markin, R. & Purtilo, D. T. Fatal infectious mononucleosis and virus-associated hemophagocytic syndrome. Arch. Pathol. Lab Med.111, 530–535 (1987). CASPubMed Google Scholar
Sullivan, J. L. & Woda, B. A. X-linked lymphoproliferative syndrome. Immunodefic. Rev.1, 325–347 (1989). CASPubMed Google Scholar
Harrington, D. S., Weisenburger, D. D. & Purtilo, D. T. Malignant lymphoma in the X-linked lymphoproliferative syndrome. Cancer59, 1419–1429 (1987). CASPubMed Google Scholar
Grierson, H. & Purtilo, D. T. Epstein–Barr virus infections in males with the X-linked lymphoproliferative syndrome. Ann. Intern. Med.106, 538–545 (1987). CASPubMed Google Scholar
Parolini, O. et al. Analysis of SH2D1A mutations in patients with severe Epstein–Barr virus infections, Burkitt's lymphoma, and Hodgkin's lymphoma. Ann. Hematol.81, 441–447 (2002). CASPubMed Google Scholar
Grierson, H. L., Skare, J., Hawk, J., Pauza, M. & Purtilo, D. T. Immunoglobulin class and subclass deficiencies prior to Epstein–Barr virus infection in males with X-linked lymphoproliferative disease. Am. J. Med. Genet.40, 294–297 (1991). CASPubMed Google Scholar
Purtilo, D. T., Grierson, H. L., Ochs, H. & Skare, J. Detection of X-linked lymphoproliferative disease using molecular and immunovirologic markers. Am. J. Med.87, 421–424 (1989). CASPubMed Google Scholar
Gross, T. G. et al. Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry. Bone Marrow Transplant.17, 741–744 (1996). CASPubMed Google Scholar
Sumegi, J. et al. Correlation of mutations of the SH2D1A gene and Epstein–Barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease. Blood96, 3118–3125 (2000). This paper provides a thorough analysis of mutations of the geneSH2D1Aand phenotypes in X-linked lymphoproliferative syndrome (XLP). CASPubMed Google Scholar
Coffey, A. J. et al. Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding gene. Nature Genet.20, 129–135 (1998). CASPubMed Google Scholar
Nichols, K. E. et al. Inactivating mutations in an SH2 domain-encoding gene in X-linked lymphoproliferative syndrome. Proc. Natl Acad. Sci. USA95, 13765–13770 (1998). CASPubMedPubMed Central Google Scholar
Sayos, J. et al. The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature395, 462–469 (1998). References 16–18 describe the cloning ofSH2D1A. CASPubMed Google Scholar
Morra, M. et al. X-linked lymphoproliferative disease: a progressive immunodeficiency. Annu. Rev. Immunol.19, 657–682 (2001). CASPubMed Google Scholar
Shlapatska, L. M. et al. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. J. Immunol.166, 5480–5487 (2001). CASPubMed Google Scholar
Pawson, T. & Nash, P. Assembly of cell regulatory systems through protein interaction domains. Science300, 445–452 (2003). CASPubMed Google Scholar
Morra, M. et al. Structural basis for the interaction of the free SH2 domain EAT-2 with SLAM receptors in hematopoietic cells. EMBO J.20, 5840–5852 (2001). This paper describes the interaction of EAT2 with receptors of the signalling lymphocytic activation molecule (SLAM) family. CASPubMedPubMed Central Google Scholar
Tangye, S. G., Phillips, J. H. & Lanier, L. L. The CD2-subset of the Ig superfamily of cell surface molecules: receptor–ligand pairs expressed by NK cells and other immune cells. Semin. Immunol.12, 149–157 (2000). CASPubMed Google Scholar
Sidorenko, S. P. & Clark, E. A. The dual-function CD150 receptor subfamily: the viral attraction. Nature Immunol.4, 19–24 (2003). CAS Google Scholar
Peck, S. R. & Ruley, H. E. Ly108: a new member of the mouse CD2 family of cell surface proteins. Immunogenetics52, 63–72 (2000). CASPubMed Google Scholar
Bottino, C. et al. NTB-A, a novel SH2D1A-associated surface molecule contributing to the inability of natural killer cells to kill Epstein–Barr virus-infected B cells in X-linked lymphoproliferative disease. J. Exp. Med.194, 235–246 (2001). CASPubMedPubMed Central Google Scholar
de la Fuente, M. A., Pizcueta, P., Nadal, M., Bosch, J. & Engel, P. CD84 leukocyte antigen is a new member of the Ig superfamily. Blood90, 2398–2405 (1997). CASPubMed Google Scholar
de la Fuente, M. A. et al. Molecular cloning, characterization, and chromosomal localization of the mouse homologue of CD84, a member of the CD2 family of cell surface molecules. Immunogenetics49, 249–255 (1999). CASPubMed Google Scholar
Cocks, B. G. et al. A novel receptor involved in T-cell activation. Nature376, 260–263 (1995). This paper describes the cloning of SLAM. CASPubMed Google Scholar
Castro, A. G. et al. Molecular and functional characterization of mouse signaling lymphocytic activation molecule (SLAM): differential expression and responsiveness in TH1 and TH2 cells. J. Immunol.163, 5860–5870 (1999). CASPubMed Google Scholar
Wang, N. et al. CD150 is a member of a family of genes that encode glycoproteins on the surface of hematopoietic cells. Immunogenetics53, 382–394 (2001). CASPubMed Google Scholar
Fisher, R. C. & Thorley-Lawson, D. A. Characterization of the Epstein–Barr virus-inducible gene encoding the human leukocyte adhesion and activation antigen BLAST-1 (CD48). Mol. Cell Biol.11, 1614–1623 (1991). CASPubMedPubMed Central Google Scholar
Wong, Y. W., Williams, A. F., Kingsmore, S. F. & Seldin, M. F. Structure, expression, and genetic linkage of the mouse BCM1 (OX45 or Blast-1) antigen. Evidence for genetic duplication giving rise to the BCM1 region on mouse chromosome 1 and the CD2/LFA3 region on mouse chromosome 3. J. Exp. Med.171, 2115–2130 (1990). CASPubMed Google Scholar
Boles, K. S., Stepp, S. E., Bennett, M., Kumar, V. & Mathew, P. A. 2B4 (CD244) and CS1: novel members of the CD2 subset of the immunoglobulin superfamily molecules expressed on natural killer cells and other leukocytes. Immunol. Rev.181, 234–249 (2001). CASPubMed Google Scholar
Bouchon, A., Cella, M., Grierson, H. L., Cohen, J. I. & Colonna, M. Activation of NK cell-mediated cytotoxicity by a SAP-independent receptor of the CD2 family. J. Immunol.167, 5517–5521 (2001). CASPubMed Google Scholar
Murphy, J. J. et al. A novel immunoglobulin superfamily receptor (19A) related to CD2 is expressed on activated lymphocytes and promotes homotypic B-cell adhesion. Biochem. J.361, 431–436 (2002). CASPubMedPubMed Central Google Scholar
Tovar, V. et al. Mouse novel Ly9: a new member of the expanding CD150 (SLAM) family of leukocyte cell-surface receptors. Immunogenetics54, 394–402 (2002). CASPubMed Google Scholar
Sandrin, M. S. et al. Isolation and characterization of cDNA clones for mouse Ly-9. J. Immunol.149, 1636–1641 (1992). CASPubMed Google Scholar
Sandrin, M. S. et al. Isolation and characterization of cDNA clones for Humly9: the human homologue of mouse Ly9. Immunogenetics43, 13–19 (1996). CASPubMed Google Scholar
de la Fuente, M. A. et al. Molecular characterization and expression of a novel human leukocyte cell-surface marker homologous to mouse Ly-9. Blood97, 3513–3520 (2001). CASPubMed Google Scholar
Mathew, P. A. et al. Cloning and characterization of the 2B4 gene encoding a molecule associated with non-MHC-restricted killing mediated by activated natural killer cells and T cells. J. Immunol.151, 5328–5337 (1993). CASPubMed Google Scholar
Boles, K. S. et al. Molecular characterization of a novel human natural killer cell receptor homologous to mouse 2B4. Tissue Antigens54, 27–34 (1999). CASPubMed Google Scholar
Kingsbury, G. A. et al. Cloning, expression, and function of BLAME, a novel member of the CD2 family. J. Immunol.166, 5675–5680 (2001). CASPubMed Google Scholar
Zhang, W. et al. Genetic approach to insight into the immunobiology of human dendritic cells and identification of CD84-H1, a novel CD84 homologue. Clin. Cancer Res.7, S822–S829 (2001). Google Scholar
Fennelly, J. A., Tiwari, B., Davis, S. J. & Evans, E. J. CD2F-10: a new member of the CD2 subset of the immunoglobulin superfamily. Immunogenetics53, 599–602 (2001). CASPubMed Google Scholar
Fraser, C. C. et al. Identification and characterization of SF2000 and SF2001, two new members of the immune receptor SLAM/CD2 family. Immunogenetics53, 843–850 (2002). CASPubMed Google Scholar
Morra, M. et al. Alterations of the X-linked lymphoproliferative disease gene SH2D1A in common variable immunodeficiency syndrome. Blood98, 1321–1325 (2001). CASPubMed Google Scholar
Nistala, K. et al. X-linked lymphoproliferative disease: three atypical cases. Clin. Exp. Immunol.126, 126–130 (2001). CASPubMedPubMed Central Google Scholar
Arico, M. et al. Haemophagocytic lymphohistiocytosis: proposal of a diagnostic algorithm based on perforin expression. Br. J. Haematol.119, 180–188 (2002). PubMed Google Scholar
Sumazaki, R. et al. SH2D1A mutations in Japanese males with severe Epstein–Barr virus-associated illnesses. Blood98, 1268–1270 (2001). CASPubMed Google Scholar
Wu, C. et al. Genomic organization and characterization of mouse SAP, the gene that is altered in X-linked lymphoproliferative disease. Immunogenetics51, 805–815 (2000). CASPubMed Google Scholar
Nagy, N. et al. SH2D1A and SLAM protein expression in human lymphocytes and derived cell lines. Int. J. Cancer88, 439–447 (2000). CASPubMed Google Scholar
Shinozaki, K. et al. Activation-dependent T cell expression of the X-linked lymphoproliferative disease gene product SLAM-associated protein and its assessment for patient detection. Int. Immunol.14, 1215–1223 (2002). CASPubMed Google Scholar
Nakamura, H., Zarycki, J., Sullivan, J. L. & Jung, J. U. Abnormal T cell receptor signal transduction of CD4 TH cells in X-linked lymphoproliferative syndrome. J. Immunol.167, 2657–2665 (2001). CASPubMed Google Scholar
Tangye, S. G. et al. Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J. Immunol.162, 6981–6985 (1999). CASPubMed Google Scholar
Benoit, L., Wang, X., Pabst, H. F., Dutz, J. & Tan, R. Defective NK cell activation in X-linked lymphoproliferative disease. J. Immunol.165, 3549–3553 (2000). CASPubMed Google Scholar
Parolini, S. et al. X-linked lymphoproliferative disease. 2B4 molecules displaying inhibitory rather than activating function are responsible for the inability of natural killer cells to kill Epstein–Barr virus-infected cells. J. Exp. Med.192, 337–346 (2000). CASPubMedPubMed Central Google Scholar
Feldhahn, N. et al. Silencing of B cell receptor signals in human naive B cells. J. Exp. Med.196, 1291–1305 (2002). CASPubMedPubMed Central Google Scholar
Poy, F. et al. Crystal structures of the XLP protein SAP reveal a class of SH2 domains with extended, phosphotyrosine-independent sequence recognition. Mol. Cell4, 555–561 (1999). This key study showed the crystal structure of SAP (SLAM-associated protein) binding to SLAM peptides. CASPubMed Google Scholar
Howie, D. et al. Molecular dissection of the signaling and co-stimulatory functions of CD150 (SLAM): CD150/SAP binding and CD150-mediated co-stimulation. Blood99, 957–965 (2002). CASPubMed Google Scholar
Sayos, J. et al. Cell surface receptors Ly-9 and CD84 recruit the X-linked lymphoproliferative disease gene product SAP. Blood97, 3867–3874 (2001). CASPubMed Google Scholar
Li, C., Iosef, C., Jia, C. Y., Han, V. K. & Li, S. S. Dual functional roles for the X-linked lymphoproliferative syndrome gene product SAP/SH2D1A in signaling through the signaling lymphocyte activation molecule (SLAM) family of immune receptors. J. Biol. Chem.278, 3852–3859 (2003). CASPubMed Google Scholar
Tatsuo, H., Ono, N. & Yanagi, Y. Morbilliviruses use signaling lymphocyte activation molecules (CD150) as cellular receptors. J. Virol.75, 5842–5850 (2001). CASPubMedPubMed Central Google Scholar
Hahm, B. et al. Measles virus infects and suppresses proliferation of T lymphocytes from transgenic mice bearing human signaling lymphocytic activation molecule. J. Virol.77, 3505–3515 (2003). CASPubMedPubMed Central Google Scholar
Baorto, D. M. et al. Survival of FimH-expressing enterobacteria in macrophages relies on glycolipid traffic. Nature389, 636–639 (1997). CASPubMed Google Scholar
Brown, M. H. et al. 2B4, the natural killer and T cell immunoglobulin superfamily surface protein, is a ligand for CD48. J. Exp. Med.188, 2083–2090 (1998). CASPubMedPubMed Central Google Scholar
Mavaddat, N. et al. Signaling lymphocytic activation molecule (CDw150) is homophilic but self-associates with very low affinity. J. Biol. Chem.275, 28100–28109 (2000). CASPubMed Google Scholar
Wang, J. H. et al. Structure of a heterophilic adhesion complex between the human CD2 and CD58 (LFA-3) counterreceptors. Cell97, 791–803 (1999). CASPubMed Google Scholar
Davis, S. J. et al. The nature of molecular recognition by T cells. Nature Immunol.4, 217–224 (2003). CAS Google Scholar
Moran, M. & Miceli, M. C. Engagement of GPI-linked CD48 contributes to TCR signals and cytoskeletal reorganization: a role for lipid rafts in T cell activation. Immunity9, 787–796 (1998). CASPubMed Google Scholar
Watzl, C. & Long, E. O. Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts. J. Exp. Med.197, 77–85 (2003). CASPubMedPubMed Central Google Scholar
Aversa, G., Chang, C. C., Carballido, J. M., Cocks, B. G. & De Vries, J. E. Engagement of the signaling lymphocytic activation molecule (SLAM) on activated T cells results in IL-2-independent, cyclosporin A-sensitive T cell proliferation and IFN-γ production. J. Immunol.158, 4036–4044 (1997). CASPubMed Google Scholar
Howie, D. et al. The role of SAP in murine CD150 (SLAM)-mediated T-cell proliferation and interferon-γ production. Blood100, 2899–2907 (2002). CASPubMed Google Scholar
Sidorenko, S. P. & Clark, E. A. Characterization of a cell surface glycoprotein IPO-3, expressed on activated human B and T lymphocytes. J. Immunol.151, 4614–4624 (1993). CASPubMed Google Scholar
Punnonen, J. et al. Soluble and membrane-bound forms of signaling lymphocytic activation molecule (SLAM) induce proliferation and Ig synthesis by activated human B lymphocytes. J. Exp. Med.185, 993–1004 (1997). CASPubMedPubMed Central Google Scholar
Mikhalap, S. V. et al. CDw150 associates with src-homology 2-containing inositol phosphatase and modulates CD95-mediated apoptosis. J. Immunol.162, 5719–5727 (1999). CASPubMed Google Scholar
Latour, S. et al. Regulation of SLAM-mediated signal transduction by SAP, the X-linked lymphoproliferative gene product. Nature Immunol.2, 681–690 (2001). CAS Google Scholar
Wu, C. et al. SAP controls T cell responses to virus and terminal differentiation of TH2 cells. Nature Immunol.2, 410–414 (2001). This paper describes the phenotype of Sap-deficient mice, providing evidence that this molecule is essential for cytokine production after infection. CAS Google Scholar
Martin, M. et al. CD84 functions as a homophilic adhesion molecule and enhances IFN-γ secretion: adhesion is mediated by Ig-like domain 1. J. Immunol.167, 3668–3676 (2001). CASPubMed Google Scholar
Chuang, S. S., Kumaresan, P. R. & Mathew, P. A. 2B4 (CD244)-mediated activation of cytotoxicity and IFN-γ release in human NK cells involves distinct pathways. J. Immunol.167, 6210–6216 (2001). CASPubMed Google Scholar
Garni-Wagner, B. A., Purohit, A., Mathew, P. A., Bennett, M. & Kumar, V. A novel function-associated molecule related to non-MHC-restricted cytotoxicity mediated by activated natural killer cells and T cells. J. Immunol.151, 60–70 (1993). CASPubMed Google Scholar
Bottino, C. et al. Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells. Eur. J. Immunol.30, 3718–3722 (2000). CASPubMed Google Scholar
Klem, J., Verrett, P. C., Kumar, V. & Schatzle, J. D. 2B4 is constitutively associated with linker for the activation of T cells in glycolipid-enriched microdomains: properties required for 2B4 lytic function. J. Immunol.169, 55–62 (2002). CASPubMed Google Scholar
Tangye, S. G., Phillips, J. H., Lanier, L. L. & Nichols, K. E. Functional requirement for SAP in 2B4-mediated activation of human natural killer cells as revealed by the X-linked lymphoproliferative syndrome. J. Immunol.165, 2932–2936 (2000). CASPubMed Google Scholar
Nakajima, H. et al. Patients with X-linked lymphoproliferative disease have a defect in 2B4 receptor-mediated NK cell cytotoxicity. Eur. J. Immunol.30, 3309–3318 (2000). CASPubMed Google Scholar
Aoukaty, A. & Tan, R. Association of the X-linked lymphoproliferative disease gene product SAP/SH2D1A with 2B4, a natural killer cell-activating molecule, is dependent on phosphoinositide 3-kinase. J. Biol. Chem.277, 13331–13337 (2002). CASPubMed Google Scholar
Henning, G. et al. Signaling lymphocytic activation molecule (SLAM) regulates T cellular cytotoxicity. Eur. J. Immunol.31, 2741–2750 (2001). CASPubMed Google Scholar
Latour, S. et al. Binding of SAP SH2 domain to FynT SH3 domain reveals a novel mechanism of receptor signalling in immune regulation. Nature Cell Biol.5, 149–154 (2003). CASPubMed Google Scholar
Chan, B. et al. SAP couples Fyn to SLAM immune receptors. Nature Cell Biol.5, 155–160 (2003). References 88 and 89 show that SAP recruits FYN to SLAM. CASPubMed Google Scholar
Sivori, S. et al. Early expression of triggering receptors and regulatory role of 2B4 in human natural killer cell precursors undergoing in vitro differentiation. Proc. Natl Acad. Sci. USA99, 4526–4531 (2002). CASPubMedPubMed Central Google Scholar
Shlapatska, L. M. et al. CD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phosphatase is regulated by the adaptor protein SH2D1A. J. Immunol.166, 5480–5487 (2001). CASPubMed Google Scholar
Czar, M. J. et al. Altered lymphocyte responses and cytokine production in mice deficient in the X-linked lymphoproliferative disease gene SH2D1A/DSHP/SAP. Proc. Natl Acad. Sci. USA98, 7449–7454 (2001). This paper describes the phenotype of Sap-deficient mice. CASPubMedPubMed Central Google Scholar
Crotty, S., Kersh, E. N., Cannons, J., Schwartzberg, P. L. & Ahmed, R. SAP is required for generating long-term humoral immunity. Nature421, 282–287 (2003). An evaluation of humoral responses in Sap-deficient mice CASPubMed Google Scholar
Sharpe, A. H. & Freeman, G. J. The B7-CD28 superfamily. Nature Rev. Immunol.2, 116–126 (2002). CAS Google Scholar
Thompson, A. D. et al. EAT-2 is a novel SH2 domain containing protein that is upregulated by Ewing's sarcoma EWS/FLI1 fusion gene. Oncogene13, 2649–2658 (1996). CASPubMed Google Scholar
Tangye, S. G., van de Weerdt, B. C., Avery, D. T. & Hodgkin, P. D. CD84 is upregulated on a major population of human memory B cells and recruits the SH2 domain containing proteins SAP and EAT-2. Eur. J. Immunol.32, 1640–1649 (2002). CASPubMed Google Scholar
Lewis, J. et al. Distinct interactions of the X-linked lymphoproliferative syndrome gene product SAP with cytoplasmic domains of members of the CD2 receptor family. Clin. Immunol.100, 15–23 (2001). CASPubMed Google Scholar
Gonzalez-Cabrero, J. et al. CD48-deficient mice have a pronounced defect in CD4+ T cell activation. Proc. Natl Acad. Sci. USA96, 1019–1023 (1999). CASPubMedPubMed Central Google Scholar
Patel, V. P., Moran, M., Low, T. A. & Miceli, M. C. A molecular framework for two-step T cell signaling: Lck Src homology 3 mutations discriminate distinctly regulated lipid raft reorganization events. J. Immunol.166, 754–764 (2001). CASPubMed Google Scholar
Garnett, D., Barclay, A. N., Carmo, A. M. & Beyers, A. D. The association of the protein tyrosine kinases p56lck and p60fyn with the glycosyl phosphatidylinositol-anchored proteins Thy-1 and CD48 in rat thymocytes is dependent on the state of cellular activation. Eur. J. Immunol.23, 2540–2544 (1993). CASPubMed Google Scholar
Cinek, T. & Horejsi, V. The nature of large noncovalent complexes containing glycosyl-phosphatidylinositol-anchored membrane glycoproteins and protein tyrosine kinases. J. Immunol.149, 2262–2270 (1992). CASPubMed Google Scholar
Del Valle, J. M., Engel, P. & Martin, M. The cell surface expression of SAP-binding receptor CD229 is regulated via its interaction with clathrin-associated adaptor complex 2 (AP-2). J. Biol. Chem.278, 17430–17437 (2003). CASPubMed Google Scholar
Sayos, J. et al. Potential pathways for regulation of NK and T cell responses: differential X-linked lymphoproliferative syndrome gene product SAP interactions with SLAM and 2B4. Int. Immunol.12, 1749–1757 (2000). CASPubMed Google Scholar
Klem, J., Verrett, P. C., Kumar, V. & Schatzle, J. D. 2B4 is constitutively associated with linker for the activation of T cells in glycolipid-enriched microdomains: properties required for 2B4 lytic function. J. Immunol.169, 55–62 (2002). CASPubMed Google Scholar
Bottino, C. et al. Analysis of the molecular mechanism involved in 2B4-mediated NK cell activation: evidence that human 2B4 is physically and functionally associated with the linker for activation of T cells. Eur. J. Immunol.30, 3718–3722 (2000). CASPubMed Google Scholar
Nakajima, H. & Colonna, M. 2B4: an NK cell activating receptor with unique specificity and signal transduction mechanism. Hum. Immunol.61, 39–43 (2000). CASPubMed Google Scholar
Kumaresan, P. R., Lai, W. C., Chuang, S. S., Bennett, M. & Mathew, P. A. CS1, a novel member of the CD2 family, is homophilic and regulates NK cell function. Mol. Immunol.39, 1–8 (2002). CASPubMed Google Scholar
Davis, S. J. & van der Merwe, P. A. The structure and ligand interactions of CD2: implications for T-cell function. Immunol. Today17, 177–187 (1996). CASPubMed Google Scholar
Latchman, Y., McKay, P. F. & Reiser, H. Identification of the 2B4 molecule as a counter-receptor for CD48. J. Immunol.161, 5809–5812 (1998). CASPubMed Google Scholar
Kato, K. et al. CD48 is a counter-receptor for mouse CD2 and is involved in T cell activation. J. Exp. Med.176, 1241–1249 (1992). CASPubMed Google Scholar
Kingsmore, S. F., Souryal, C. A., Watson, M. L., Patel, D. D. & Seldin, M. F. Physical and genetic linkage of the genes encoding Ly-9 and CD48 on mouse and human chromosomes 1. Immunogenetics42, 59–62 (1995). CASPubMed Google Scholar
Watzl, C. & Long, E. O. Natural killer cell inhibitory receptors block actin cytoskeleton-dependent recruitment of 2B4 (CD244) to lipid rafts. J. Exp. Med.197, 77–85 (2003). CASPubMedPubMed Central Google Scholar